255 related articles for article (PubMed ID: 6148312)
1. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Kirch W; Axthelm T
Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
3. [Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
Welzel D; Bräutigam M
Arzneimittelforschung; 1989 Apr; 39(4):499-503. PubMed ID: 2568838
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effect of bopindolol: a multi-centre study.
Török E; Szám I; Buday G; Kerkovits G; Farsang C; Hajtman B
J Hum Hypertens; 1990 Aug; 4(4):458-60. PubMed ID: 1979635
[TBL] [Abstract][Full Text] [Related]
5. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
Honorato J; Galende I; Catalán M; Azanza JR
Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
[TBL] [Abstract][Full Text] [Related]
6. [The effect of the blood pressure lowering effect of bopindolol (Sandonorm) in patients with mild and moderate hypertension].
Zsáry A; Káldi N; Kállay K
Orv Hetil; 1991 Sep; 132(39):2149-51. PubMed ID: 1681490
[TBL] [Abstract][Full Text] [Related]
7. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z
Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Paran E; Holzberg G; Mazor M; Zmora E; Insler V
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
[TBL] [Abstract][Full Text] [Related]
9. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
Andersson OK; Hedner T; Nyberg G
Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
[TBL] [Abstract][Full Text] [Related]
11. The antihypertensive effect of atenolol and bopindolol in the elderly.
Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J
Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension].
Bagatin J; Kuzmanić A; Rumboldt Z; Mirić D; Naranca M; Obad M; Pivac N; Polić S; Rakić D
Med Pregl; 1990; 43(3-4):145-8. PubMed ID: 1978233
[TBL] [Abstract][Full Text] [Related]
13. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
Ishibashi T; Mitomi A; Tatebe S; Imai S
Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
Bjerle P; Jacobsson KA; Agert G
Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
[No Abstract] [Full Text] [Related]
15. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
Schiess W; Welzel D; Gugler R
Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
[TBL] [Abstract][Full Text] [Related]
16. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
17. MIS (Multicentric Isradipine Study of antihypertensive therapy).
Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension.
van Brummelen P; Bühler FR; Amann FW; Bolli P
Eur J Clin Pharmacol; 1982; 22(6):491-3. PubMed ID: 6127218
[TBL] [Abstract][Full Text] [Related]
19. Dose-finding study with bopindolol in arterial hypertension.
Willimann P; Peter R; Siegenthaler H
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
[TBL] [Abstract][Full Text] [Related]
20. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
